Skip to product information
TESAMORELIN
$340.000,00 COP
What is it?
Tesamorelin is an analog of growth hormone-releasing hormone (GHRH).
What is it used for?
Tesamorelin does have a specific approved medical indication in the United States: Egrifta WR is indicated to reduce excess abdominal fat in adults with HIV and lipodystrophy.
Benefits studied/approved
-
Stimulation of growth hormone production.
-
Reduction of abdominal fat in the specific population for which it is approved.
-
Research related to body composition.